Literature DB >> 21597466

Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells.

Cédric Hesling1, Laurent Fattet, Guillaume Teyre, Delphine Jury, Philippe Gonzalo, Jonathan Lopez, Christophe Vanbelle, Anne-Pierre Morel, Germain Gillet, Ivan Mikaelian, Ruth Rimokh.   

Abstract

TGF-β is a potent inducer of epithelial-to-mesenchymal transition (EMT), a process involved in tumour invasion. TIF1γ participates in TGF-β signalling. To understand the role of TIF1γ in TGF-β signalling and its requirement for EMT, we analysed the TGF-β1 response of human mammary epithelial cell lines. A strong EMT increase was observed in TIF1γ-silenced cells after TGF-β1 treatment, whereas Smad4 inactivation completely blocked this process. Accordingly, the functions of several TIF1γ target genes can be linked to EMT, as shown by microarray analysis. As a negative regulator of Smad4, TIF1γ could be crucial for the regulation of TGF-β signalling. Furthermore, TIF1γ binds to and represses the plasminogen activator inhibitor 1 promoter, demonstrating a direct role of TIF1γ in TGF-β-dependent gene expression. This study shows the molecular relationship between TIF1γ and Smad4 in TGF-β signalling and EMT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21597466      PMCID: PMC3128966          DOI: 10.1038/embor.2011.78

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  23 in total

1.  Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.

Authors:  Wei He; David C Dorn; Hediye Erdjument-Bromage; Paul Tempst; Malcolm A S Moore; Joan Massagué
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 2.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

3.  The Shwachman-Bodian-Diamond syndrome associated protein interacts with HsNip7 and its down-regulation affects gene expression at the transcriptional and translational levels.

Authors:  Cédric Hesling; Carla C Oliveira; Beatriz A Castilho; Nilson I T Zanchin
Journal:  Exp Cell Res       Date:  2007-07-10       Impact factor: 3.905

4.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

5.  Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo.

Authors:  Leonardo Morsut; Kai-Ping Yan; Elena Enzo; Mariaceleste Aragona; Sandra M Soligo; Olivia Wendling; Manuel Mark; Konstantin Khetchoumian; Giorgio Bressan; Pierre Chambon; Sirio Dupont; Régine Losson; Stefano Piccolo
Journal:  Development       Date:  2010-06-23       Impact factor: 6.868

6.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.

Authors:  Ulrich Valcourt; Marcin Kowanetz; Hideki Niimi; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Mol Biol Cell       Date:  2005-02-02       Impact factor: 4.138

7.  TIF1gamma, a novel member of the transcriptional intermediary factor 1 family.

Authors:  L Venturini; J You; M Stadler; R Galien; V Lallemand; M H Koken; M G Mattei; A Ganser; P Chambon; R Losson; H de Thé
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

Review 8.  Non-Smad TGF-beta signals.

Authors:  Aristidis Moustakas; Carl-Henrik Heldin
Journal:  J Cell Sci       Date:  2005-08-15       Impact factor: 5.285

9.  The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.

Authors:  Martine Deckers; Maarten van Dinther; Jeroen Buijs; Ivo Que; Clemens Löwik; Gabri van der Pluijm; Peter ten Dijke
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

10.  Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase.

Authors:  Sirio Dupont; Luca Zacchigna; Michelangelo Cordenonsi; Sandra Soligo; Maddalena Adorno; Massimo Rugge; Stefano Piccolo
Journal:  Cell       Date:  2005-04-08       Impact factor: 41.582

View more
  30 in total

1.  Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.

Authors:  Payam Mohassel; Paul Rosen; Livia Casciola-Rosen; Katherine Pak; Andrew L Mammen
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

2.  Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.

Authors:  L Wang; H Yang; Z Lei; J Zhao; Y Chen; P Chen; C Li; Y Zeng; Z Liu; X Liu; H-T Zhang
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 3.  Regulation of TGF-β signal transduction by mono- and deubiquitylation of Smads.

Authors:  Sirio Dupont; Masafumi Inui; Stuart J Newfeld
Journal:  FEBS Lett       Date:  2012-03-24       Impact factor: 4.124

4.  Tif1γ suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway.

Authors:  David F Vincent; Johann Gout; Nicolas Chuvin; Vanessa Arfi; Roxane M Pommier; Philippe Bertolino; Nicolas Jonckheere; Doriane Ripoche; Bastien Kaniewski; Sylvie Martel; Jean-Baptiste Langlois; Sophie Goddard-Léon; Amélie Colombe; Marc Janier; Isabelle Van Seuningen; Régine Losson; Ulrich Valcourt; Isabelle Treilleux; Pierre Dubus; Nabeel Bardeesy; Laurent Bartholin
Journal:  Am J Pathol       Date:  2012-03-31       Impact factor: 4.307

5.  Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.

Authors:  Xiaopeng Lan; Guoliang Lu; Chuanwei Yuan; Shaowei Mao; Wei Jiang; Yougen Chen; Xunbo Jin; Qinghua Xia
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-24       Impact factor: 4.553

6.  Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.

Authors:  Angeles C Tecalco-Cruz; Marcela Sosa-Garrocho; Genaro Vázquez-Victorio; Layla Ortiz-García; Elisa Domínguez-Hüttinger; Marina Macías-Silva
Journal:  J Biol Chem       Date:  2012-06-06       Impact factor: 5.157

Review 7.  Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.

Authors:  E-Jean Tan; Anna-Karin Olsson; Aristidis Moustakas
Journal:  Cell Adh Migr       Date:  2014-11-17       Impact factor: 3.405

Review 8.  Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment.

Authors:  Shuang Li; Jing Zhao; Dong Shang; Daniel J Kass; Yutong Zhao
Journal:  JCI Insight       Date:  2018-05-17

9.  TIF1γ protein regulates epithelial-mesenchymal transition by operating as a small ubiquitin-like modifier (SUMO) E3 ligase for the transcriptional regulator SnoN1.

Authors:  Yoshiho Ikeuchi; Shorafidinkhuja Dadakhujaev; Amrita S Chandhoke; Mai Anh Huynh; Anna Oldenborg; Mikako Ikeuchi; Lili Deng; Eric J Bennett; J Wade Harper; Azad Bonni; Shirin Bonni
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

10.  Signaling crosstalk between TGFβ and Dishevelled/Par1b.

Authors:  A Mamidi; M Inui; A Manfrin; S Soligo; E Enzo; M Aragona; M Cordenonsi; O Wessely; S Dupont; S Piccolo
Journal:  Cell Death Differ       Date:  2012-05-11       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.